- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01680783
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
Mechanical Ventilation in Patients With \Respiratory Failure: A Comparison of Face Mask and Non Invasive Ventilation Via a Helmet Device
Study Overview
Status
Conditions
Detailed Description
Respiratory failure is often treated with endotracheal intubation and mechanical ventilation. Although, the institution of mechanical ventilation is considered life saving, the associated complications of tracheal stenosis, ventilator associated pneumonia, barotrauma , and neuromuscular weakness are not without considerable morbidity and mortality.
Non-invasive ventilation has demonstrated significant benefit in patients with hypercapnic respiratory failure from COPD, acute cardiogenic pulmonary edema, and hypoxemic respiratory failure in immunocompromised patients.
Despite the advantages of non-invasive ventilation via facemask, some patients fail because of mask intolerance and severity of disease. Further limitation to facemask non-invasive ventilation is that the seal integrity is lost when higher pressures are required. Unfortunately, certain types of respiratory failure such as that due to hypoxemia or shock may require such higher pressures.
In an attempt to improve patient tolerability and deliver higher pressures, a transparent helmet has been proposed as a novel interface for non-invasive ventilation. It encloses the entire head and neck of the patient. The design of the helmet confers some important advantages: 1) the transparency allows the patient to interact with the environment; 2) the lack of contact to the face lowers the risk of skin necrosis; 3) the helmet avoids problems of leaking with higher airway pressures that are seen with the face mask; 4) it can be applied to any patient regardless of facial contour.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- University of Chicago Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients aged ≥18 years of age who require noninvasive ventilation via facemask for >8hours
- Intact airway protective gag reflex
- Able to follow instructions
Exclusion Criteria:
- Cardiopulmonary arrest
- Glasgow coma scale <8
- Absence of airway protective gag reflex
- Elevated intracranial pressure
- Tracheostomy
- Upper airway obstruction
- Pregnancy.
- Patients who refuse to undergo endotracheal intubation, whatever the initial therapeutic approach
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Usual Care
Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask.
|
Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask
Other Names:
|
Experimental: Non invasive ventilation via helmet
Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure
|
Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Need for Endotracheal Intubation
Time Frame: 6 weeks
|
Number of patients requiring endotracheal intubation after application of helmet device
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospital Length of Stay
Time Frame: Duration of hospital stay
|
Days spent in hospital at time of enrollment
|
Duration of hospital stay
|
Number of Participants Functional Status After Discharge
Time Frame: Measured at 1, 6, and 12 months after hospital discharge (to span time frame of up to 80 weeks depending on length of hospitalization)
|
Telephone survey of patients 1, 6, and 12 months after discharge to assess need for re-hospitalization, admission to nursing home, and functional status (ability to complete ADLs and IADLs independently)
|
Measured at 1, 6, and 12 months after hospital discharge (to span time frame of up to 80 weeks depending on length of hospitalization)
|
Ventilator-free Days
Time Frame: number of days in the hospital
|
Duration of mechanical ventilation via endotracheal tube
|
number of days in the hospital
|
Hospital Mortality
Time Frame: 90 days
|
Death from any cause during hospitalization at time of enrollment
|
90 days
|
Intensive Care Unit Length of Stay
Time Frame: 4 weeks
|
Number of days admitted to a medical intensive care unit
|
4 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ICU Complications
Time Frame: 6 weeks
|
ICU complications will include rates of Ventilator associated pneumonia, Barotrauma, Gastrointestinal hemorrhage, Pulmonary embolism, Sacral Decubitus ulcer, Delirium, ICU acquired weakness
|
6 weeks
|
Readmission to the Intensive Care Unit
Time Frame: 6 weeks
|
Measure the need for readmission to the intensive care unit during initial hospitalization at time of enrollment
|
6 weeks
|
Discharge Location
Time Frame: 6 weeks
|
Measure the location (ie home, rehabilitation center, nursing home) that patients are discharged to
|
6 weeks
|
Improvement of Oxygenation
Time Frame: 2 weeks
|
Improvement of oxygenation-defined as PaO2/FiO2 ≥ 200 or increase from baseline by 100
|
2 weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Respiratory Tract Diseases
- Respiration Disorders
- Lung Diseases
- Infant, Newborn, Diseases
- Signs and Symptoms, Respiratory
- Lung Injury
- Infant, Premature, Diseases
- Respiratory Insufficiency
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Acute Lung Injury
- Pulmonary Edema
- Hypoventilation
Other Study ID Numbers
- 12-1391
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shock
-
Assistance Publique - Hôpitaux de ParisTraumabase Group; Capgemini Invent; Ecole polytechnique; EHESS (Ecole des hautes... and other collaboratorsRecruitingWounds and Injuries | Hemorrhagic Shock | Traumatic ShockFrance
-
Biomedizinische Forschungs gmbHMedical University of ViennaCompletedSepsis | Toxic-Shock Syndrome
-
King's College Hospital NHS TrustUniversity Hospital BirminghamCompletedTraumatic Haemorrhagic ShockUnited Kingdom
-
Haukeland University HospitalMinistry of Defence, NorwayCompletedHemorrhagic Shock | Hypovolemic ShockNorway
-
National Institute of Allergy and Infectious Diseases...Completed
-
Massachusetts General HospitalBeth Israel Deaconess Medical Center; Boston Medical Center; Tufts Medical Center and other collaboratorsRecruiting
-
Jason SperryNational Heart, Lung, and Blood Institute (NHLBI)TerminatedHemorrhagic ShockUnited States
-
University of Texas Southwestern Medical CenterUniversity of Washington; Resuscitation Outcomes ConsortiumCompletedHemorrhagic ShockUnited States
-
Ramathibodi HospitalUnknownSeptic Shock | Refractory ShockThailand
-
Assiut UniversityUnknown
Clinical Trials on Noninvasive ventilation via facemask
-
VA Office of Research and DevelopmentCompletedSleep Apnea | AgeUnited States
-
University Hospital, Clermont-FerrandNot yet recruitingDyspnea | Chronic Obstructive Pulmonary Disease SevereFrance
-
The First Affiliated Hospital of Guangzhou Medical...UnknownCOPD | Hypercapnic Respiratory FailureChina
-
Hamilton Health Sciences CorporationRecruiting
-
UPECLIN HC FM Botucatu UnespUnknownExtubation Failure | Acute Respiratory Failure Post ExtubationBrazil
-
Jie LiBinzhou Medical UniversityCompletedChronic Obstructive Pulmonary Disease With (Acute) ExacerbationChina
-
University Hospital, MontpellierCompletedRespiratory Failure | Non Invasive Ventilation on Healthy VolunteerFrance
-
Patri-cia Angelica de Miranda Silva NogueiraCompletedHeart Failure
-
University Hospital, BordeauxCompletedRespiratory FailureFrance
-
Universidade Federal de PernambucoPronto Socorro Cardiológico de Pernambuco-PROCAPECompletedHeart FailureBrazil